Shlokka Dyes Limited’s Board of Directors convened on November 3, 2026, approving the unaudited standalone financial results for the half-year ended September 30, 2026. Key decisions also included increasing the authorized share capital from ₹22 crore to ₹29 crore, and approving the creation and allotment of up to 39,00,000 warrants and 31,00,000 equity shares via preferential issue, subject to shareholder approval.
Board Approves Financials and Capital Infusion
Shlokka Dyes Limited announced significant outcomes from its Board of Directors meeting held on Tuesday, November 3, 2026. The Board reviewed and approved the unaudited standalone financial results for the half-year ended September 30, 2026, along with the accompanying Limited Review Report. These results will be made available on the company’s website.
Share Capital Enhancement
In a strategic move to support future growth, the authorized share capital of the company has been increased. The existing capital of ₹22,00,00,000 (Rupees Twenty-Two Crore) divided into 2,20,00,000 Equity Shares of ₹10 each, will be enhanced to ₹29,00,00,000 (Rupees Twenty-Nine Crore) divided into 2,90,00,000 Equity Shares of ₹10 each. This revision is subject to shareholder approval and necessitates amendments to Clause V of the Memorandum of Association.
Warrant Issuance for Fundraising
The Board also approved the creation and proposed issuance of up to 39,00,000 warrants, fully convertible into equity shares. These warrants will be offered on a preferential basis to promoters, the promoter group, and the public at an issue price of ₹35 per warrant (including a premium of ₹25). The total value of this issuance is approximately ₹13,65,00,000. Terms include 25% payment at application and the balance upon conversion into equity shares, with conversion exercisable within 18 months.
Preferential Issue of Equity Shares
Further, the company plans to issue up to 31,00,000 equity shares of face value ₹10 each, also on a preferential basis. These shares will be offered to non-promoters/public at an issue price of ₹35 per share (including a ₹25 premium), aggregating up to approximately ₹10,85,00,000. This issuance is also contingent upon shareholder and regulatory approvals.
Extra-Ordinary General Meeting Scheduled
To seek necessary approvals for these proposals, the company will convene its First Extra-Ordinary General Meeting for FY 2026-2027 on Saturday, November 28, 2026, at 03:30 P.M. IST, conducted via video conferencing. M/s. Insiya Nalawala & Associates has been appointed as scrutinizer for the remote e-voting process, with NSDL appointed as the remote e-voting agency. The cut-off date for e-voting has also been fixed.
Financial Highlights
The unaudited standalone statement of assets and liabilities as of September 30, 2026, shows total assets of ₹16,275.12 Lakhs. The standalone profit and loss statement for the half-year ended September 30, 2026, reports a profit before tax of ₹630.83 Lakhs and a profit after tax of ₹521.05 Lakhs. The cash flow statement indicates a net cash inflow from operating activities of ₹272.96 Lakhs for the half-year ended September 30, 2026.
Auditor’s Limited Review Report
The Independent Auditor’s Limited Review Report on the unaudited standalone financial results for the half-year ended September 30, 2026, was issued by Patel & Panchal, Chartered Accountants. The report highlights an emphasis of matter regarding a related party business acquisition on a slump purchase basis and a change in the accounting estimate for depreciation method. The auditors concluded that nothing came to their attention to suggest material misstatements.
Source: BSE
